coronary disease, acute coronary syndrome, ST-segment elevation
DISEASE INTERVENTION COMPARISON RESULTS
JAMA. 2006 Apr 5;295(13):1519-30. Epub 2006 Mar 14 Randomized Controlled Trial, Multicenter Study
IN coronary disease, acute coronary syndrome, ST-segment elevation The Use of
pentasacharide analogues, fondaparinux (2.5 mg/d) for 8 days
As Treatment, Acute
Is better Than
unfractionated heparin for 2 days, or placebo
To reduce at 30 days bad outcome (death or reinfarction): 9.7% fondaparinux VS 11.2% controls. No difference in bleeding.